Benjamin Gomez

Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.

Knopp Neurosciences, Inc. operates as a drug discovery and development company. It focused on delivering breakthrough treatments in neurological disorders. It operates through three areas: inflammation discovery platform, mitochondrial discovery platform, and ion channel discovery platform. The company was founded by Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.

Pilot House Associates LLC engages in the provision of investment services. The company is headquartered in Boston, MA.

GBH operates radio and television stations. The firm provides Public media powerhouse with educational content that informs, inspires and entertains. The company was founded by Ralph Lowell on 02 May, 1995 and is headquartered in Boston, MA.

WGBH Educational Foundation operates television stations. The non-profit company is based in Boston, MA and has subsidiaries in United States. The company was founded in 1951 by Ralph Lowell. Jonathan C. Abbott has been the CEO of the company since 1998.

Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials.

Youth Communication/New York Center, Inc. engages in publishing magazines, books, and other materials. It offers workshops and lesson plans for educators who want to use its stories in schools, after school programs, and foster care agencies. The company was founded in 1980 and is headquartered in New York, NY.

Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA.